Site US10055 — Kansas City, Kansas

Site US10055 is a clinical research site located in Kansas City, Kansas, United States 66160-7233.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site US10055 has participated in 1 clinical trials.

Therapeutic areas: Metastatic Hormone Sensitive Prostate Cancer.

Sponsors: Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US10055?

Site US10055 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US10055 conducted?

Site US10055 has 1 clinical trials on record. Their work covers Metastatic Hormone Sensitive Prostate Cancer.

Is Site US10055 accredited by Crixeo Health?

Site US10055 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US10055?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.